Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) saw some unusual options trading on Monday. Stock traders acquired 37,996 put options on the stock. This is an increase of approximately 549% compared to the typical daily volume of 5,859 put options.
Bath & Body Works Trading Up 6.2 %
Shares of NYSE:BBWI traded up $1.70 during midday trading on Monday, reaching $28.91. The company had a trading volume of 3,572,878 shares, compared to its average volume of 3,309,798. Bath & Body Works has a 52-week low of $26.20 and a 52-week high of $52.99. The company’s 50 day moving average price is $33.36 and its 200 day moving average price is $41.29. The stock has a market cap of $6.45 billion, a P/E ratio of 7.44, a P/E/G ratio of 0.86 and a beta of 1.77.
Bath & Body Works Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio is currently 20.62%.
Hedge Funds Weigh In On Bath & Body Works
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on BBWI. Evercore ISI lowered their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 28th. Robert W. Baird lowered their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Morgan Stanley cut their price target on shares of Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research note on Thursday, September 5th. Barclays lowered their target price on shares of Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating on the stock in a report on Thursday, August 29th. Finally, Piper Sandler reduced their price objective on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. Eight research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $43.00.
Check Out Our Latest Research Report on BBWI
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Health Care Stocks Explained: Why You Might Want to Invest
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Compound Interest and Why It Matters When Investing
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Do ETFs Pay Dividends? What You Need to Know
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.